更可靠的肿瘤指标,或多种标志物联合测定进行互补可从而提高诊断的敏感性和特异性,为良恶性腹腔积液的鉴别诊断提供更加准确可行的手段。参考文献:[1]许凯声,黄洪,杨旭峰,等.C反应蛋白检测在判断胸腹水积液性质中的价值[J].检验医学,2006,21(3):2412243.[2]JosephJ,BadrinathP,BasranGS,etal.Isthepleuralfluidtransudateorexudates?Arevistofthediagnosticcriteria[J].Thorax,2001,56(11):867.[3]李春芸,魏小斌,符芳玲,等.中性溯胞弹性蛋白酶(NE)在鉴别渗出液和漏出液中的意义[J].中国热带医学,2006,6(2):321.[4]姜建玉.测定胸腹水pH、CEA、铁蛋白鉴别恶性肿瘤[J].临床检验杂志,1999,17(5):319.[5]RotenbergZ,WeinbergerI,SagleA,etal.Totallactatedehydrogenaseanditsisoenzymesinserumofpatientswithnon2small2celllungcancer[J].ClinChem,1998,34(4):6682670.[6]SevincA,SariR,FadilliogluE.Theutilityoflactatedehydrogenaseisoenzymepatterninthediagnosticevaluationofmalignantandnorma2lignantascites[J].JNatlMedAssoc,2005,97(1):79284.[7]张淑艳,王北宁.胸腹水LDH和与血清LDH比值及TP测定的临床鉴别诊断价值[J].华北国防医药,2006,18(4):2762277.[8]GulyasM,KaposiAD,ElekG,etal.Valueofcarcinoembryonicantigen(CEA)andcholesterolassaysofasciticfluidincasesofinconclusivecytology[J].JClinPathol,2001,54(11):8312835.[9]华国平,倪润洲,高岩.联合检测CEA、Tch和ADA对腹水病因的鉴别诊断价值[J].南京医科大学学报,2004,18(6):3012303.[10]BurgessLJ,SwanepoelCG,TaljaardJJ.Theuseofadenosinedeaminaseasadiagnostictoolforperitonealtuberculosis[J].Tuberculosis(Ed2inb),2001,81(3):2432248.[11]刘冬妍,赵爱农,王彦峰.检测肿瘤标记物、LDH、ADA对良恶性腹水鉴别诊断价值[J].中国实验诊断学,2005,9(4):6122614.[12]LiCP,HuangTS,ChaoY,etal.Advantagesofassayingtelomeraseac2tivityinascitesfordiagnosisofdigestivetractmalignancies[J].WorldJGastroenterol,2004,10(17):246822471.[13]司君利,贺远龙,李文利,等.端粒酶检测对良恶性腹水鉴别诊断的价值[J].临床内科杂志,2004,21(4):2492251.[14]SchofieldK,AquilaT,RimmDL.E2cadherinexpressionisasensitiveandspecificmethodfordetectionofcarcinomacellsinfluidspecimens[J].DiagnCytopathol,2000,22(5):2632267.[15]SunXM,DongWG,YuBP,etal.DetectionoftypeIVcollagenaseac2tivityinmalignantascites[J].WorldJGastroenterol,2003,9(11):259222595.[16]UngerKM,RaberM,BedrossianCW,etal.Analysisofpleuraleffu2sionsusingautomatedflowcytometry[J].Cancer,1983,52(5):8732877.[17]陈涛,王锡清.恶性肿瘤患者的胸腹水染色体检查[J].海南医学,2001,12(2):122.[18]NascimentoI,SchaerR,LemaireD,etal.Vascularendothelialgrowthfactor(VEGF)levelsasatooltodiscriminatebetweenmalignantandnonmalignantascites[J].Apmis,2004,112(9):5852587.[19]吴建红,孙晓敏.可溶性CD44v6和Ⅳ型胶原酶在恶性腹水中的诊断价值[J].武汉大学学报(医学版),2005,26(5):6462648.[20]SingerG,RebmannV,ChenYC,etal.HLA2Gisapotentialtumormarkerinmalignantascites[J].ClinCancerRes,2003,9(10):446024464.[21]ChungYS,YamashitaY,KatoY,etal.PrognosticsignificanceofTan2tigenexpressioninpatientswithgastriccarcinoma[J].Cancer,1996,77(9):176821773.[22]杨少波,吴本俨,王孟薇.良恶性腹水中T抗原的检测及意义[J].中国肿瘤防治杂志,2006,13(5):3862387.[23]AlexandrakisMG,MoschandreaJA,KoulocheriSA,etal.Discrimina2tionbetweenmalignantandnonmalignantascitesusingserumandascit2icfluidproteinsinamultivariateanalysismodel[J].DigDisSci,2000,45(3):5002508.收稿日期:2007206226修回日期:2007212226临床医学痤疮的治疗进展谭美乐1,李建民2(1.广西医科大学研究生院,南宁530021;2.广西医科大学第三附属医院皮肤科,南宁530031)中图分类号:R758.733文献标识码:A文章编号:100622084(2008)0520688203摘要:痤疮是一种毛囊皮脂...
